US Renal Data System 2020 Annual Data Report

 Here's the USRDS Annual Data Report for 2020. Volume 2 concerns End Stage Renal Disease (ESRD)

Incidence, Prevalence, Patient Characteristics, and Treatment Modalities

"Across the 18 ESRD Networks, adjusted incidence of ESRD in 2018 ranged from 284.6 cases per million in Network 1 (New England) to 434.6 cases per million in Network 14 (Texas) (Table 1.2).

"The adjusted incidence of ESRD among Blacks fell 1.7% between 2017 and 2018. The ratio of adjusted incidence in Blacks versus Whites was 2.7, the lowest value since at least 1980 (Figure 1.4).

"The adjusted prevalence of ESRD increased to a new high of 2,242 cases per million people in 2018 (Figure 1.5).

"At the end of 2018, there were 554,038 (70.7%) patients undergoing dialysis and 229,887 (29.3%) patients with a functioning kidney transplant (Figure 1.6).

Transplantation

"In 2018, the cumulative number of kidney transplants reached an all-time high of 22,393, an increase of 6.5% since 2017 (Figure 6.9). However, the kidney transplant rate among ESRD patients increased only slightly between 2017 and 2018, from 3.5 to 3.6 transplants per 100 patient-years.

"In 2018, the number of patients with ESRD who were newly added to the kidney transplant waiting list hit an all-time high of 26,726 patients (Figure 6.1).

"The total number of individuals with ESRD on the kidney transplant waiting list hit an all-time high in 2014 (Figure 6.2). Since that time, it has decreased, but the decrease has been predominantly among those with inactive status, with only a small decline in those on the waiting list with active status.

...

"The percentage of prevalent ESRD patients who received dialysis and were on the waiting list for a kidney transplant reached 13.5% at the end of 2018 (Figure 6.4), continuing a decrease that began in 2013

...

"Adjusted 1-year graft survival among deceased donor transplant recipients in 2017 improved to 93.0%, and adjusted 1-year graft survival among living donor transplant recipients in 2017 was 96.9% (Figure 6.16)."